Lack of BCL10 mutations in Hodgkin's disease-derived cell lines

Br J Haematol. 2000 May;109(2):420-2. doi: 10.1046/j.1365-2141.2000.02052.x.

Abstract

The pathogenetic events leading to the malignant transformation of Hodgkin-Reed-Sternberg cells are unknown. As Hodgkin-Reed-Sternberg cells are resistant to CD95-mediated apoptosis and chromosomal aberrations involving the 1p22 region harbouring the proapoptotic BCL10 gene represent a recurrent event in Hodgkin's disease-derived cell lines, analysis of the BCL10 gene and its transcripts was performed. As transcription of wild-type BCL10 was detected in all Hodgkin's disease-derived cell lines analysed, alterations of the coding sequence of the BCL10 gene are unlikely to contribute to the malignant transformation of the Hodgkin-Reed-Sternberg cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing*
  • Alleles
  • B-Cell CLL-Lymphoma 10 Protein
  • Cell Line, Transformed
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 1
  • Hodgkin Disease / genetics*
  • Humans
  • Mutation
  • Neoplasm Proteins / genetics*
  • Polymerase Chain Reaction / methods
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Sequence Analysis, DNA

Substances

  • Adaptor Proteins, Signal Transducing
  • B-Cell CLL-Lymphoma 10 Protein
  • BCL10 protein, human
  • Neoplasm Proteins